A major new study involving nearly 1,900 older adults suggests that discontinuing statin therapy after age 70 may be relatively safe in the short term for individuals with no history of heart attack or stroke. The research, which examined outcomes among seniors taking the widely prescribed cholesterol-lowering drugs, found no significant increase in immediate health risks for those who stopped treatment compared with those who continued. The findings could inform clinical discussions about medication burden and quality of life for older patients, a growing demographic in many countries.
However, the study also reported a higher rate of serious cardiovascular events or death among participants who stopped statins when researchers extended follow-up over a longer period. That secondary finding has raised questions about the potential risks of discontinuing the medications, which are among the most commonly prescribed worldwide. Researchers cautioned that the results do not establish that stopping statins is safe for all older adults and called for further investigation to clarify which patients might benefit from continued treatment. Clinicians are advised to weigh individual risk factors before making changes to statin regimens.
Independent reporting synthesized from primary wires and global correspondents.